Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrenkel Topping Regulatory News (FEN)

Share Price Information for Frenkel Topping (FEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.00
Bid: 50.00
Ask: 54.00
Change: 0.00 (0.00%)
Spread: 4.00 (8.00%)
Open: 52.00
High: 52.00
Low: 52.00
Prev. Close: 52.00
FEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

8 Nov 2023 16:30

RNS Number : 8352S
Frenkel Topping Group PLC
08 November 2023

Frenkel Topping Group plc

("Frenkel Topping", the "Company" or the "Group")

Director/PDMR Dealing

Frenkel Topping (AIM: FEN), a specialist financial and professional services firm operating within the personal injury and clinical negligence marketplace, announces that on 8 November 2023 it was informed that Richard Fraser, Chief Executive Officer, has purchased 26,000 ordinary shares of 0.5p each in the capital of the Company ("Ordinary Shares"), from his wife, Norma Fraser's SIPP for estate and tax planning purposes , at a price of 53.5p pence per Ordinary Share.

Following the transaction in the Company's ordinary shares Mr. Fraser's (and persons closely associated ("PCAs") to him) beneficial holding in the Company will remain unchanged at 1,895,907 Ordinary Shares of the Company, representing approximately 1.68 per cent. of the Company's issued share capital.

For further information:

Frenkel Topping Group plc

www.frenkeltoppinggroup.co.uk

Richard Fraser, Chief Executive Officer

Tel: 0161 886 8000

finnCap Ltd (Nominated Advisor & Broker)

Tel: 020 7220 0500

Carl Holmes/Abigail Kelly (Corporate Finance)

Tim Redfern / Charlotte Sutcliffe (ECM)

About Frenkel Topping Group:

The Frenkel Topping Group of companies specialises in providing financial advice and asset protection services to clients at times of financial vulnerability, with particular expertise in the field of personal injury (PI) and clinical negligence (CN).

For more than 30 years the Group has worked with legal professionals and injured clients themselves to provide pre-settlement, at-settlement and post-settlement services to help achieve the best long-term outcomes for clients after injury. It boasts a client retention rate of 99%.

Frenkel Topping Group is focused on consolidating the fragmented PI and CN space in order to provide the most comprehensive suite of services to clients and deliver a best-in-class service offering from immediately after injury or illness and for the rest of their lives.

The group's services include the Major Trauma Signposting Partnership service inside NHS Major Trauma Centres, expert witness, costs, tax and forensic accountancy, independent financial advice, investment management, and care and case management.

The Group's discretionary fund manager, Ascencia, manages financial portfolios for clients in unique circumstances, often who have received a financial settlement after litigation. In recent years Ascencia has diversified its portfolios to include a Sharia-law-compliant portfolio and a number of ESG portfolios in response to increased interest in socially responsible investing (SRI).

Frenkel Topping has earned a reputation for commercial astuteness underpinned by a strong moral obligation to its clients, employees and wider society, with a continued focus on its Environmental, Social and Governance (ESG) impact.

For more information visit: www.frenkeltoppinggroup.co.uk

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Richard Fraser

2.

Reason for the Notification

a)

Position/status

Richard Fraser, Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Frenkel Topping Group plc

b)

LEI

213800I5L3K7AT7A4R20

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

New Ordinary Shares

Identification code

GB00B01YXQ71

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Volume(s)

Prices (pence)

26,000

53.5p

d)

Aggregated information:

· Aggregated volume

· Price

e)

Date of the transaction

8 November 2023

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Norma Fraser

2.

Reason for the Notification

a)

Position/status

PCA of Richard Fraser, Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Frenkel Topping Group plc

b)

LEI

213800I5L3K7AT7A4R20

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

New Ordinary Shares

Identification code

GB00B01YXQ71

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Volume(s)

Prices (pence)

26,000

53.5p

d)

Aggregated information:

· Aggregated volume

· Price

e)

Date of the transaction

8 November 2023

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHQVLFBXFLLFBD
Date   Source Headline
21st Sep 20169:27 amRNSHolding(s) in Company
15th Sep 20165:36 pmRNSHolding(s) in Company
15th Sep 20165:26 pmRNSDirector/PDMR Shareholding
26th Aug 20163:21 pmRNSHolding(s) in Company
26th Aug 20163:15 pmRNSDirector/PDMR Shareholding
26th Aug 20168:32 amRNSHolding(s) in Company
23rd Aug 20167:00 amRNSExercise of Options
23rd Aug 20167:00 amRNSExercise of Options
23rd Aug 20167:00 amRNSExercise of Options and Total Voting Rights
16th Aug 20167:00 amRNSTrading Update
3rd Aug 20167:00 amRNSDirector/PDMR Shareholding
11th Jul 20167:00 amRNSHalf-year Report
22nd Jun 20167:00 amRNSNotice of Results
16th Jun 20162:02 pmRNSDirector/PDMR Shareholding
16th Jun 20167:00 amRNSDirectorate Change
14th Jun 20162:10 pmRNSHolding(s) in Company
14th Jun 20162:10 pmRNSHolding(s) in Company
18th May 201610:38 amRNSResult of AGM
18th May 20167:00 amRNSAGM Statement
5th May 20163:46 pmRNSDirector Dealing
26th Apr 20168:21 amRNSChange of Adviser
6th Apr 20163:16 pmRNSDirector/PDMR Shareholding
1st Apr 20163:48 pmRNSDirector/PDMR Shareholding
31st Mar 201610:06 amRNSDirector/PDMR Shareholding
24th Mar 201611:48 amRNSDirector/PDMR Shareholding
14th Mar 201610:28 amRNSFCA Permissions Received
14th Mar 20167:00 amRNSFinal Results
26th Jan 20169:05 amRNSCorrection: Trading and strategy update
25th Jan 20167:00 amRNSTrading and strategy update and notice of results
11th Nov 20158:53 amRNSHolding(s) in Company
6th Oct 20159:52 amRNSExercise of Options
9th Sep 20154:44 pmRNSHolding(s) in Company - Replacement
8th Sep 20153:52 pmRNSHolding(s) in Company
7th Sep 20155:57 pmRNSHolding(s) in Company
1st Sep 20157:03 amRNSAcquisition and Board Appointment
18th Aug 20152:25 pmRNSDirector/PDMR Shareholding
13th Jul 20154:41 pmRNSInterim Dividend Timetable
13th Jul 20157:00 amRNSInterim Results
19th May 201510:44 amRNSResult of AGM
19th May 20157:00 amRNSAGM Statement
23rd Mar 20157:00 amRNSFinal Results
10th Feb 20157:00 amRNSHolding(s) in Company
6th Feb 201510:05 amRNSHolding(s) in Company
19th Jan 20157:00 amRNSTrading Update and Notice of Results
16th Dec 20143:16 pmRNSHolding(s) in Company
15th Dec 20143:02 pmRNSDirector/PDMR Shareholding
21st Nov 20149:48 amRNSDirector/PDMR Shareholding
21st Jul 20147:00 amRNSInterim Results
23rd Jun 201411:18 amRNSHolding(s) in Company
2nd Jun 20144:04 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.